Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Johnson & Johnson
(NY:
JNJ
)
158.19
+0.23 (+0.15%)
Official Closing Price
Updated: 7:00 PM EDT, Mar 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Johnson & Johnson
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Inaugural International Healthcare Week promotes Hong Kong as leading healthcare hub
October 31, 2022
Via
ACN Newswire
Exposures
COVID-19
Eli Lilly Dividend: Does Eli Lilly Pay Dividends?
October 27, 2022
Yes, Eli Lilly and Company (NYSE: LLY) pays dividends but there is more to investing in this stock than a simple “yes” answer. The Eli Lilly dividend is safe enough but it may not be right for all...
Via
MarketBeat
MarketBeat: Week in Review 10/17-10/21
October 22, 2022
Stocks are staging a rally to end the week. But economic data next week may bring more volatility. Here are some of the most popular articles from this week
Via
MarketBeat
Topics
Economy
Exposures
Economy
Interest Rates
Merck Nears Breakout Point After October Surprise Good News
October 19, 2022
Dow component Merck is within 2% of an all-time high after rallying 7.30% in the past month. It got a boost from news about two new treatments.
Via
MarketBeat
Topics
Stocks
Exposures
US Equities
Does J&J Have Enough Alpha to Be a Solid Low Beta Stock?
October 19, 2022
JNJ stock is seen as a defensive play which has typically done well in bear markets. But there is one issue that makes longer-term forecasts uncertain
Via
MarketBeat
Topics
Economy
Exposures
Economy
Johnson & Johnson Reports Q3 2022 Results
October 18, 2022
From
Johnson & Johnson
Via
Business Wire
Is Pfizer Stock Still Worth Buying After the Pandemic?
October 12, 2022
Pharmaceutical giant Pfizer (NYSE: PFE) is literally synonymous with COVID-19 vaccines, and as a result, Pfizer stock continues to beat expectations.
Via
MarketBeat
Exposures
COVID-19
Janssen celebrates World Mental Health Day to raise awareness on the importance of timely diagnosis and treatment
October 10, 2022
Janssen, Pharmaceutical Companies of Johnson & Johnson, is immensely proud of the many ground-breaking mental health innovations has pioneered over the course of its 60+ year legacy in the field.
Via
Newswire.com
Johnson & Johnson to Participate in the Credit Suisse 31st Annual Healthcare Conference
October 03, 2022
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson Announces Kenvue as the Name for Planned New Consumer Health Company
September 28, 2022
From
Johnson & Johnson
Via
Business Wire
3 Defensive Stocks With 60-Year Dividend Hike Streaks
September 21, 2022
With the U.S. economy staring at another recession, it may be a good time to lean on the stability and income of the dividend growth champs.
Via
MarketBeat
Topics
Economy
Exposures
COVID-19
Economy
Johnson & Johnson Opens State-of-the-Art Science and Technology Campus in San Francisco Bay Area
September 20, 2022
From
Johnson & Johnson
Via
Business Wire
Oracle’s Short-Term Pain Could Be Your Long-Term Gain
September 20, 2022
Database and cloud solutions provider Oracle (NASDAQ: ORCL) stock got smoked on its fiscal Q1 2023 earnings report. Shares were holding up relatively
Via
MarketBeat
Johnson & Johnson Announces $5 Billion Share Repurchase Program
September 14, 2022
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
September 13, 2022
From
Johnson & Johnson
Via
Business Wire
Monkeypox vaccine and research related stocks taking center stage (VRAX,GOVX,TNXP,APDN)
September 02, 2022
Via
AB Newswire
Exposures
COVID-19
aCommerce and Johnson & Johnson Launch Sustainable Packaging Solution for a Better E-commerce Future in the Philippines
September 01, 2022
Via
ACN Newswire
Worldwide Acne Treatment Market Is Projected to Reach About USD 8.69 Billion by 2028, with a CAGR of 5.1%
August 30, 2022
Acne Treatment Market SWOT Analysis Including Key Players Allergan plc, Almirall, S.A., Bausch Health Companies Inc., F. Hoffmann-la Roche Ltd., Galderma S.A. (Nestle S.A.), GlaxoSmithKline Plc (GSK),...
Via
SBWire
Shock Absorbers: 3 Low Volatility Dividend Stocks for Bumpy Times
August 30, 2022
Low volatility dividend plays are built to show their worth over time. These three stocks have historically helped navigate investors through turbulent waters.
Via
MarketBeat
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Johnson & Johnson Appoints Larry Merlo as Non-Executive Chair Designate of Planned New Consumer Health Company
August 24, 2022
From
Johnson & Johnson
Via
Business Wire
Agilis Consulting Group Appoints Former Johnson & Johnson Employee, Denise Wagner, as Principal Human Factors Consultant
August 11, 2022
Agilis is looking forward to continued growth with Denise as the Principal Consultant to help clients achieve their regulatory goals and create safer medical products for the end users.
Via
Newswire.com
New Drugs in Pipeline for Hypertension, the Silent Global Pandemic
August 10, 2022
Via
Investor Brand Network
Exposures
Product Safety
Johnson & Johnson to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
August 09, 2022
From
Johnson & Johnson
Via
Business Wire
Are Medtronic And Intuitive Surgical Poised For Big Growth?
August 09, 2022
Health care is one of the better-performing sectors in 2022, with medical gear makers Medtronic and Intuitive Surgical outpacing the broader industry recently.
Via
MarketBeat
Topics
ETFs
Exposures
COVID-19
New Drugs in Pipeline for Hypertension, the Silent Global Pandemic
August 10, 2022
NetworkNewsWire Editorial Coverage New York, NY – August 10, 2022 – In medicine, there is a term called “clinical inertia,” or the case of what someone doesn’t know — or what they ignore — could kill...
Via
FinancialNewsMedia
Exposures
Product Safety
Mathai Mammen, M.D., Ph.D., Leaves Position as Executive Vice President, Pharmaceuticals, R&D, Johnson & Johnson
August 08, 2022
From
Johnson & Johnson
Via
Business Wire
Is Church & Dwight Co. Inc. (NYSE: CHD) a Buy for Dividend Investors?
August 05, 2022
Church & Dwight (NYSE: CHD) might not exactly be a household name, but you've likely heard of many of the company's brands: ARM & HAMMER, Trojan, First Response, Nair, Spinbrush, OxiClean, Orajel,...
Via
MarketBeat
Johnson & Johnson to Participate in the 2022 Wells Fargo Securities Healthcare Conference
August 02, 2022
From
Johnson & Johnson
Via
Business Wire
Hot Debate Over Myocarditis Risk Shines Spotlight on Heart Disease
July 26, 2022
Palm Beach, FL – July 26, 2022 – FinancialNewsMedia.com News Commentary – As COVID-19 vaccines for kids achieve the Centers for Disease Control and Prevention (CDC) recommendation, concern it could...
Via
FinancialNewsMedia
Exposures
COVID-19
Product Safety
MarketBeat: Week in Review 7/18 – 7/22
July 22, 2022
Investors should be careful not to read too much into this week's rally. Next week will bring the Fed's decision on interest rates and key earnings reports from the tech sector. Both could cause...
Via
MarketBeat
Topics
Economy
Exposures
Economy
Interest Rates
Supply Chain
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.